1Life Healthcare Inc. (NASDAQ:ONEM) shares traded higher over the last trading session, gaining 2.54% on 05/26/21. The shares fell to a low of $34.01 before closing at $35.15. Intraday shares traded counted 1.42 million, which was -19.7% lower than its 30-day average trading volume of 1.19M. ONEM’s previous close was $34.28 while the outstanding shares total 136.52M. The stock’s Relative Strength Index (RSI) is 40.09, with weekly volatility at 4.65% and ATR at 2.03. The ONEM stock’s 52-week price range has touched low of $25.40 and a $59.82 high.
Investors have identified the Health Information Services company 1Life Healthcare Inc. as an interesting stock but before investments are made there, an in-depth look at its trading activities will have to be conducted. The share is trading with a market value of around $4.91 billion, the company now has both obstacles and catalysts that affect them and they came from their mode of operations. With the company affected by events currently, it is a perfect time to analyze the numbers behind the firm in order to come up with a rather realistic picture of what this stock is.
1Life Healthcare Inc. (ONEM) Fundamentals that are to be considered.
When analyzing a stock, the first fundamental thing to take into account is the balance sheet. How healthy the balance sheet of a company is will determine if the company will be able to carry out all its financial and non-financial obligations and also keep the faith of its investors. In terms of their assets, the company currently has 790.66 million total, with 143.09 million as their total liabilities.
Having a look at the company’s valuation, the company is expected to record -0.37 total earnings per share during the next fiscal year. It is very important though to remember that the importance of trend far outweighs that of outlook. This analysis has been great and getting further updates on ONEM sounds very interesting.
Is the stock of ONEM attractive?
In related news, General Counsel and Secretary, Mango Lisa A sold 1,915 shares of the company’s stock in a transaction that recorded on Apr 26. The sale was performed at an average price of 42.15, for a total value of 80,716. As the sale deal closes, the General Counsel and Secretary, Mango Lisa A now sold 687 shares of the company’s stock, valued at 28,860. Also, General Counsel and Secretary, Mango Lisa A sold 1,500 shares of the company’s stock in a deal that was recorded on Apr 22. The shares were price at an average price of 42.04 per share, with a total market value of 63,062. Following this completion of acquisition, the Chief Technology Officer, Lockhart Kimber D now holds 30,000 shares of the company’s stock, valued at 1,241,838. In the last 6 months, insiders have changed their ownership in shares of company stock by 0.40%.
13 out of 14 analysts covering the stock have rated it a Buy, while 1 have maintained a Hold recommendation on 1Life Healthcare Inc.. 0 analysts has assigned a Sell rating on the ONEM stock. The 12-month mean consensus price target for the company’s shares has been set at $51.90.